Rumneek Bedi

Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome

Rishi P. Singh, Ang Li, Rumneek Bedi et al. · British Journal of Ophthalmology · 2013 · 127 citations

Medicine, Ophthalmology, Surgery +16

A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis

Rishi P. Singh, Sunil K. Srivastava, Justis P. Ehlers et al. · British Journal of Ophthalmology · 2014 · 74 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

OUTCOMES OF TREATMENT OF CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY WITH INTRAVITREAL ANTIANGIOGENIC AGENTS

Jay Chhablani, Igor Kozak, Francesco Pichi et al. · Retina · 2015 · 59 citations

Medicine, Ophthalmology, Pharmacotherapy +13

Oral eplerenone for the management of chronic central serous chorioretinopathy.

Rishi P. Singh, Jonathan E. Sears, Rumneek Bedi et al. · PubMed · 2015 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +2

A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis

Rishi P. Singh, Peter K. Kaiser, Sunil Srivastava et al. · Clinical ophthalmology · 2015 · 31 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17